Basel Medical (BMGL) Cash & Current Investments (2024 - 2025)

Basel Medical's (BMGL) quarterly Cash & Current Investments came in at $2.3 million in Q2 2025, up 62.19% year-on-year from $1.4 million in Q2 2024, and up 19.88% quarter-over-quarter from $2.0 million in Q4 2024.

Basel Medical (BMGL) Cash & Current Investments (2024 - 2025) Analysis & Trends

Basel Medical has disclosed Cash & Current Investments across 2 years of filings, most recently posting $2.3 million for Q2 2025.

  • Cash & Current Investments for Q2 2025 came in at $2.3 million, up 62.19% year-over-year; the trailing twelve-month figure through Jun 2025 was $2.3 million (up 62.19% YoY), and the FY2025 annual result was $2.3 million, up 62.19% from the prior year.
  • Cash & Current Investments came in at $2.3 million for Q2 2025 at Basel Medical, up from $2.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.3 million in Q2 2025 to a low of $1.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn 940.00 Mn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 2.97 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 666.55 Mn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn 163.40 Mn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn 595.18 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 119.03 Mn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 2.38 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 16.86 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn 247.98 Mn
10 Basel Medical 8.86 Mn 6.52 Mn - 2.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 2.34 Mn
Dec 31, 2024 1.95 Mn
Jun 30, 2024 1.44 Mn